June 14, 2013
Impax Laboratories Inc. has agreed to license Shire PLC's patents for the attention deficit hyperactivity disorder drug Intuniv, resolving Shire's infringement litigation over Impax's bid to launch a generic version of the drug, according to settlement papers filed Thursday in California federal court.
August 29, 2011
A California federal judge on Monday denied Impax Laboratories Inc. and Watson Pharmaceuticals Inc.'s attempt to dismiss a patent infringement suit brought by Irish drugmaker Shire PLC over a generic version of its attention deficit hyperactivity disorder drug Intuniv.